Publications by authors named "Gerd Laux"

Claim this Profile
A
A factor analytic comparison of three commonly used depression scales (HAMD, MADRS, BDI) in a large sample of depressed inpatients.
Florian Seemüller, Rebecca Schennach, Richard Musil, Michael Obermeier, Mazda Adli, Gerd Laux

BMC Psychiatry· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Parkinson and depression: review and outlook.
Gerd Laux

J Neural Transm (Vienna)· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic vs non-chronic depression in psychiatric inpatient care - Data from a large naturalistic multicenter trial.
Florian Seemüller, Miriam Kolter, Richard Musil, Rebecca Schennach, Mazda Adli, Gerd Laux

J Affect Disord· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Driving Performance Under Treatment of Most Frequently Prescribed Drugs for Mental Disorders: A Systematic Review of Patient Studies.
Alexander Brunnauer, Florian Herpich, Peter Zwanzger, Gerd Laux

Int J Neuropsychopharmacol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining machine learning algorithms for prediction of antidepressant treatment response.
Alexander Kautzky, Hans-Juergen Möller, Markus Dold, Lucie Bartova, Florian Seemüller, Gerd Laux

Acta Psychiatr Scand· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What happens with schizophrenia patients after their discharge from hospital? Results on outcome and treatment from a "real-world" 2-year follow-up trial.
Rebecca Schennach, Michael Riedel, Michael Obermeier, Markus Jäger, Max Schmauss, Gerd Laux

Eur Arch Psychiatry Clin Neurosci· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Dopamine Receptor Antagonism of Opipramol: Relevance to Parkinsonism?
Verena Rozanski, Gerd Laux, Johannes Schwarz

Clin Neuropharmacol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Erratum to: Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP].
Stefan Unterecker, Gudrun Hefner, Pierre Baumann, Gerd Gründer, Niels Bergemann, Gerd Laux

Nervenarzt· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing Schizophrenia Patients With a Predicted High/Low Risk of Nonresponse Receiving Treatment with Ziprasidone and Haloperidol: A Randomized-Controlled Study.
Rebecca Schennach, Michael Riedel, Ilja Spellmann, Richard Musil, Michael Obermeier, Gerd Laux

Pharmacopsychiatry· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remission in schizophrenia - What are we measuring? Comparing the consensus remission criteria to a CGI-based definition of remission and to remission in major depression.
Rebecca Schennach, Michael Obermeier, Ilja Spellmann, Florian Seemüller, Richard Musil, Gerd Laux

Schizophr Res· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Comparing Schizophrenia Patients With a Predicted High/Low Risk of Nonresponse Receiving Treatment with Ziprasidone and Haloperidol: A Randomized-Controlled Study.
Rebecca Schennach, Michael Riedel, Ilja Spellmann, Richard Musil, Michael Obermeier, Gerd Laux

Pharmacopsychiatry· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Therapeutic drug monitoring in neuropsychopharmacology : Summary of the consensus guidelines 2017 of the TDM task force of the AGNP].
Stefan Unterecker, Gudrun Hefner, Pierre Baumann, Gerd Gründer, Niels Bergemann, Gerd Laux

Nervenarzt· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TDM in psychiatry and neurology: A comprehensive summary of the consensus guidelines for therapeutic drug monitoring in neuropsychopharmacology, update 2017; a tool for clinicians.
Georgios Schoretsanitis, Michael Paulzen, Stefan Unterecker, Markus Schwarz, Andreas Conca, Gerd Laux

World J Biol Psychiatry· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A standardized stepwise drug treatment algorithm for depression reduces direct treatment costs in depressed inpatients - Results from the German Algorithm Project (GAP3).
Roland Ricken, Katja Wiethoff, Thomas Reinhold, Thomas J Stamm, Thomas C Baghai, Gerd Laux

J Affect Disord· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subtypes of depression and their overlap in a naturalistic inpatient sample of major depressive disorder.
Richard Musil, Florian Seemüller, Sebastian Meyer, Ilja Spellmann, Mazda Adli, Gerd Laux

Int J Methods Psychiatr Res· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How Effective Is Algorithm-Guided Treatment for Depressed Inpatients? Results from the Randomized Controlled Multicenter German Algorithm Project 3 Trial.
Mazda Adli, Katja Wiethoff, Thomas C Baghai, Robert Fisher, Florian Seemüller, Gerd Laux

Int J Neuropsychopharmacol· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Driving Under the Influence of Antidepressants: A Systematic Review and Update of the Evidence of Experimental and Controlled Clinical Studies.
Alexander Brunnauer, Gerd Laux

Pharmacopsychiatry· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Editorial to Driving Ability and Psychotropic Drugs].
Gerd Laux, Michael Bauer

Pharmacopsychiatry· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Add-on Antidepressants in the Naturalistic Treatment of Schizophrenia Spectrum Disorder - When, Who, and How?
Rebecca Schennach, Michael Obermeier, Florian Seemüller, Markus Jäger, Max Schmauss, Gerd Laux

Pharmacopsychiatry· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validity of remission and recovery criteria for schizophrenia and major depression: comparison of the results of two one-year follow-up naturalistic studies.
Ilja Spellmann, Rebecca Schennach, Florian Seemüller, Sebastian Meyer, Richard Musil, Gerd Laux

Eur Arch Psychiatry Clin Neurosci· June 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pooled Analysis of Four Non-Interventional Studies: Effectiveness and Tolerability of the Antidepressant Agomelatine in Daily Practice.
Gerd Laux, Bettina Barthel, Göran Hajak, Matthias Lemke, Hans-Peter Volz

Adv Ther· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A proposal for a psychopharmacology-pharmacotherapy catalogue of learning objectives and a curriculum in Europe.
Pierre Baumann, Marie Spies, Hans-Jürgen Möller, Siegfried Kasper, Istvan Bitter, Gerd Laux

World J Biol Psychiatry· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Update Psychopharmacotherapy.
Gerd Laux

Med Monatsschr Pharm· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stability of remission rates in a 3-year follow-up of naturalistic treated depressed inpatients.
Florian Seemüller, Michael Obermeier, Rebecca Schennach, Michael Bauer, Mazda Adli, Gerd Laux

BMC Psychiatry· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Driving ability in mental illness].
Gerd Laux

MMW Fortschr Med· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis